CA2283648C - Excipient polymere - Google Patents

Excipient polymere Download PDF

Info

Publication number
CA2283648C
CA2283648C CA002283648A CA2283648A CA2283648C CA 2283648 C CA2283648 C CA 2283648C CA 002283648 A CA002283648 A CA 002283648A CA 2283648 A CA2283648 A CA 2283648A CA 2283648 C CA2283648 C CA 2283648C
Authority
CA
Canada
Prior art keywords
pla
polymer
polymeric composition
stereoselective
copolymers
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CA002283648A
Other languages
English (en)
Other versions
CA2283648A1 (fr
Inventor
Avraham J. Domb
Zeev Zehavi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Efrat Biopolymers Ltd
Original Assignee
Efrat Biopolymers Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Efrat Biopolymers Ltd filed Critical Efrat Biopolymers Ltd
Publication of CA2283648A1 publication Critical patent/CA2283648A1/fr
Application granted granted Critical
Publication of CA2283648C publication Critical patent/CA2283648C/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
    • A61K9/1647—Polyesters, e.g. poly(lactide-co-glycolide)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Other Resins Obtained By Reactions Not Involving Carbon-To-Carbon Unsaturated Bonds (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)

Abstract

L'invention concerne un excipient polymère destiné à l'administration d'une molécule bioactive ou bioréactive, l'excipient comprenant un stéréocomplexe d'au moins un polymère stéréosélectif biocompatible et d'une molécule bioactive ou bioréactive.
CA002283648A 1998-01-14 1999-01-14 Excipient polymere Expired - Fee Related CA2283648C (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IL122933 1998-01-14
IL12293398A IL122933A (en) 1998-01-14 1998-01-14 Polymeric carrier for delivery of a bioactive molecule
PCT/IL1999/000023 WO1999036100A2 (fr) 1998-01-14 1999-01-14 Excipient polymere

Publications (2)

Publication Number Publication Date
CA2283648A1 CA2283648A1 (fr) 1999-07-22
CA2283648C true CA2283648C (fr) 2007-04-17

Family

ID=11071088

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002283648A Expired - Fee Related CA2283648C (fr) 1998-01-14 1999-01-14 Excipient polymere

Country Status (6)

Country Link
EP (1) EP0967998A2 (fr)
JP (1) JP2001515522A (fr)
AU (1) AU1888999A (fr)
CA (1) CA2283648C (fr)
IL (1) IL122933A (fr)
WO (1) WO1999036100A2 (fr)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60010072T2 (de) 1999-02-19 2005-03-24 Universiteit Utrecht Stereokomplexe hydrogele
WO2000050050A1 (fr) * 1999-02-23 2000-08-31 Isis Pharmaceuticals, Inc. Formulation multiparticulaire
WO2002083166A1 (fr) * 2001-04-10 2002-10-24 Santen Pharmaceutical Co., Ltd. Complexes de polymeres d'interferons et leur utilisation medicinale
DE10154924A1 (de) * 2001-11-08 2003-05-28 Medinnova Ges Med Innovationen Bioabbaubare Kopolymere
CN1290893C (zh) * 2002-05-03 2006-12-20 詹森药业有限公司 聚合物微乳状液
US8012488B2 (en) 2005-02-18 2011-09-06 Nof Corporation Polyoxyalkylene derivative
EP1902084A2 (fr) 2005-06-01 2008-03-26 Yissum Research Development Company, of The Hebrew University of Jerusalem Polymeres biodegradables a chiralite predeterminee
JP5216995B2 (ja) * 2006-02-03 2013-06-19 国立大学法人北海道大学 ブロック共重合体からなるナノディスク
DE602008004124D1 (de) 2008-06-18 2011-02-03 Inst Biopolimerow I Wlokien Chemicznych Verfahren zur Herstellung eines polylaktischen Säurestereokomplex-Pulvers
EP2591792B1 (fr) * 2010-07-09 2016-12-21 The University of Tokyo Composition d'administration d'acides nucléiques, composition d'excipient, composition pharmaceutique contenant la composition d'administration d'acides nucléiques ou la composition d'excipient et méthode d'administration d'acides nucléiques
CN108559084B (zh) * 2018-04-13 2020-12-04 华东理工大学 一种聚乳酸基疏水薄膜的制备方法
CN109908106A (zh) * 2019-03-04 2019-06-21 北京化工大学 一种可供静脉注射的甲氨蝶呤纳米胶囊及其制备方法
JP7050734B2 (ja) * 2019-09-30 2022-04-08 鳥居薬品株式会社 舌下アレルゲン免疫療法におけるフィルム製剤
CN115785471B (zh) * 2022-12-16 2023-08-08 华中科技大学 一种二氧化碳基超分子聚合物及其制备方法和应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6136321A (ja) * 1984-07-27 1986-02-21 Daicel Chem Ind Ltd 新規なポリマ−およびその樹脂組成物
US4902515A (en) * 1988-04-28 1990-02-20 E. I. Dupont De Nemours And Company Polylactide compositions
CA2046830C (fr) * 1990-07-19 1999-12-14 Patrick P. Deluca Systeme d'administration des medicaments comprenant une interaction entre une proteine ou une polypeptide et un polymere hydrophobe biodegradable

Also Published As

Publication number Publication date
JP2001515522A (ja) 2001-09-18
WO1999036100A3 (fr) 1999-09-23
IL122933A0 (en) 1998-08-16
EP0967998A2 (fr) 2000-01-05
CA2283648A1 (fr) 1999-07-22
WO1999036100A2 (fr) 1999-07-22
AU1888999A (en) 1999-08-02
IL122933A (en) 2005-03-20

Similar Documents

Publication Publication Date Title
US6365173B1 (en) Stereocomplex polymeric carriers for drug delivery
US10300019B2 (en) Biodegradable, semi-crystalline, phase separated, thermoplastic multi block copolymers for controlled release of biologically active compounds
US7163698B2 (en) Controlled drug delivery system using the conjugation of drug to biodegradable polyester
CA2283648C (fr) Excipient polymere
Kissel et al. ABA-triblock copolymers from biodegradable polyester A-blocks and hydrophilic poly (ethylene oxide) B-blocks as a candidate for in situ forming hydrogel delivery systems for proteins
AU758838B2 (en) Biodegradable poly(alkylene oxide)-poly(p-dioxanone) block copolymer soluble in organic solvents, and drug delivery composition comprising same
ES2770273T3 (es) Administración inyectable de micropartículas y composiciones para ello
EP0912166A1 (fr) Procedes et compositions utilisant des excipients organiques pour renforcer les proprietes bioadhesives de polymeres
JP3834331B2 (ja) 表面活性剤を含有しない生体再吸収性重合体微小球、その製造及び薬剤としてその応用
US20060224095A1 (en) Biocompatible polymeric vesicles self assembled from triblock copolymers
CA2537802A1 (fr) Composition contenant des nanoparticules contenant des medicaments basiques solubles dans l'eau encapsules dans celle-ci
EP1339776B1 (fr) Polyanhydrides
WO2023177300A1 (fr) Copolymères multiblocs à base de poly(ortho-ester) thermoplastique biodégradable
Lanz Landázuri Modification of microbial polyacids for drug delivery systems
Hennink et al. 19 Fast Biodegradable Polymers
NZ620392B2 (en) Biodegradable, semi-crystalline, phase separated, thermoplastic multi block copolymers for controlled release of biologically active compounds
MXPA96004634A (en) Compositions for controlled supply, liqui

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed